XML 53 R40.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted-average Assumptions to Determine Fair Value
The weighted-average assumptions utilized to determine the fair value of options granted to employees are presented in the following table:
Year Ended December 31,
20242023
Expected volatility61.8 %63.1 %
Weighted-average risk-free interest rate4.28 %3.75 %
Expected dividend yield— — 
Expected life – in years66
Schedule of Option Activity
A summary of the Company’s option activity as of December 31, 2025, and changes during the year then ended are as follows:
Number of OptionsWeighted-Average Exercise Price (per share)Weighted-Average Remaining Contractual Term (in years)
Outstanding at December 31, 2024
5,266,163 $8.14 7.08
Granted— — 
Exercised(1,203,565)3.22 
Forfeited(172,016)10.96 
Outstanding at December 31, 2025
3,890,582 9.54 6.26
Options exercisable at December 31, 2025
3,041,602 9.496.46
Schedule of RSU Activity
A summary of RSU activity under the Company’s 2021 Plan for the year ended December 31, 2025 is as follows:
Number of SharesWeighted-Average Grant Date Fair ValueAggregate Fair Value
Unvested balance at January 1, 20254,523,499 $12.02 $54,372 
Granted7,052,742 8.10 57,127 
Vested(3,388,791)11.57 39,208 
Forfeited(583,729)8.77 5,119 
Unvested balance as of December 31, 20257,603,721$7.39 $56,191 
Schedule of PSU Activity
A summary of PSU activity under the Company’s 2021 Plan for the year ended December 31, 2025 is as follows:
Number of SharesWeighted-Average Grant Date Fair ValueAggregate Fair Value
Unvested balance at January 1, 20252,151,933 $12.21 $26,275 
Granted1,819,122 10.03 18,246 
Vested— — — 
Forfeited(838,012)11.57 9,696 
Unvested balance at December 31, 20253,133,043 $11.11 $34,808 
Schedule of Stock-based Compensation Expense The following table shows stock-based compensation expense by where the stock-based compensation expense is recorded by line item in the Company’s consolidated statements of operations:
Year Ended December 31,
202520242023
Cost of revenue$406 $239 $130 
Sales and marketing7,425 4,742 3,077 
Research and development14,764 5,906 2,213 
General and administrative30,030 17,112 9,917 
Total stock-based compensation$52,625 $27,999 $15,337